LVOne funding for CE Mark approval

We’re thrilled to share that Upfront Diagnostics has been awarded £30,000 from the MedTech Accelerator: Rapid Regulatory Support (MARRS) fund, delivered by CPI

This funding will play a pivotal role in supporting the CE marking of our stroke diagnostic device, the LVOne – a rapid, point-of-care test designed to detect stroke in minutes, helping to save lives through earlier intervention.

With this support, we’re one step closer to bringing the LVOne to market across the European Union, empowering healthcare providers with faster, more reliable diagnostic tools across emergency and acute care settings.

Stort by Upfront Diagnostics